Drug intelligence / Profile preview

Tribromometacresol

Development stage: Unknown
Modality: Small Molecules
Administration: Topical

Overview

Tribromometacresol is an antifungal medication belonging to the class of organic compounds known as meta cresols. It contains a meta-cresol moiety with a benzene ring bearing a methyl group and a hydroxyl group at ring positions 1 and 3. Tribromometacresol has been used for the treatment of dermatomycoses (fungal infections of the skin). Its mechanism of action is not fully elucidated but it acts as an antifungal agent[2][3].

Brand names: MicatexTriphysanTriphysol
Other names: tribromometacresol2,4,6-tribromo-m-cresol2,4,6-tribromo-3-hydroxytoluene2,4,6-tribromo-3-methylphenol

Beyond the preview

Go deeper on Tribromometacresol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tribromometacresol.

Explore the full profile